Clorox (NYSE:CLX) Price Target Raised to $173.00 at JPMorgan Chase & Co.

Clorox (NYSE:CLX) had its price objective boosted by JPMorgan Chase & Co. from $171.00 to $173.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 18.51% from the stock’s previous close.

A number of other research analysts have also issued reports on CLX. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI lowered their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Wells Fargo & Company upped their target price on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday. Finally, Barclays dropped their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $158.21.

Clorox Trading Down 1.5 %

Clorox stock opened at $145.98 on Tuesday. Clorox has a one year low of $127.60 and a one year high of $171.37. The company’s fifty day moving average price is $162.25 and its two-hundred day moving average price is $158.76. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company has a market capitalization of $18.07 billion, a price-to-earnings ratio of 50.86, a PEG ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same period in the prior year, the business posted $2.16 EPS. On average, analysts forecast that Clorox will post 6.86 earnings per share for the current fiscal year.

Institutional Trading of Clorox

Hedge funds have recently modified their holdings of the company. Czech National Bank increased its position in shares of Clorox by 6.6% during the third quarter. Czech National Bank now owns 25,232 shares of the company’s stock worth $4,111,000 after acquiring an additional 1,567 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Clorox by 63.0% in the 3rd quarter. GAMMA Investing LLC now owns 1,795 shares of the company’s stock valued at $292,000 after purchasing an additional 694 shares during the period. New England Research & Management Inc. bought a new stake in shares of Clorox in the third quarter valued at about $216,000. Affinity Capital Advisors LLC acquired a new position in shares of Clorox during the third quarter worth about $224,000. Finally, Axiom Advisory LLC grew its holdings in shares of Clorox by 1.6% during the third quarter. Axiom Advisory LLC now owns 11,328 shares of the company’s stock worth $1,679,000 after buying an additional 177 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.